| Potential Drug-drug Interaction between Dabrafenib and Insulin Secretagogue Repaglinide | |
| Wang, Yong-Gang; Wang, Shu-Dong; Miao, Xiao; Liu, Quan | |
| 刊名 | LATIN AMERICAN JOURNAL OF PHARMACY
 |
| 2017 | |
| 卷号 | 36期号:8 |
| 关键词 | cancer dabrafenib drug-drug interaction glucuronidation repaglinide type 2 diabetes mellitus (T2DM) UDP-glucuronosyltransferase (UGT) 1A1 |
| ISSN号 | 0326-2383 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3539376 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Wang, Yong-Gang,Wang, Shu-Dong,Miao, Xiao,et al. Potential Drug-drug Interaction between Dabrafenib and Insulin Secretagogue Repaglinide[J]. LATIN AMERICAN JOURNAL OF PHARMACY,2017,36(8). |
| APA | Wang, Yong-Gang,Wang, Shu-Dong,Miao, Xiao,&Liu, Quan.(2017).Potential Drug-drug Interaction between Dabrafenib and Insulin Secretagogue Repaglinide.LATIN AMERICAN JOURNAL OF PHARMACY,36(8). |
| MLA | Wang, Yong-Gang,et al."Potential Drug-drug Interaction between Dabrafenib and Insulin Secretagogue Repaglinide".LATIN AMERICAN JOURNAL OF PHARMACY 36.8(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论